APP and Alzheimer disease: In the past decade, it was reported that rats treated with chronic intake of Al3+ showed a significant increase in the expression of the APP gene in the cerebral cortex and hippocampus, suggesting that one of the mechanisms contributing to the neuropathological picture of Al3+ in AD is through the activation of the cascade of formation of the Aβ peptide [119].